Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Expert Opinion on Biological Therapy
|
June 20, 2022
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?
Fabiola Atzeni, Cesare Siragusano, Ignazio Francesco Masala, et al.
Clinical and Experimental Rheumatology
|
March 3, 2020
Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system
Fabiola Atzeni, Ignazio Francesco Masala, Mariateresa Cirillo, et al.
Expert Review of Clinical Immunology
|
September 20, 2024
Interstitial lung disease in rheumatic diseases: an update of the 2018 review
Fabiola Atzeni, Alessandra Alciati, Francesco Gozza, et al.
Expert Opinion on Biological Therapy
|
September 28, 2022
Effect of biological DMARDs and JAK inhibitors in pain of chronic inflammatory arthritis
Alessandra Alciati, Marco Di Carlo, Cesare Siragusano, et al.
Expert Review of Clinical Pharmacology
|
September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?
Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Autoimmunity Reviews
|
November 8, 2017
Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?
Piercarlo Sarzi-Puttini, Fabiola Atzeni, Ignazio Francesco Masala, et al.
Expert Opinion on Emerging Drugs
|
December 19, 2017
An update on emerging drugs for fibromyalgia treatment
Fabiola Atzeni, Maria Chiara Gerardi, Ignazio Francesco Masala, et al.
Best Practice & Research. Clinical Rheumatology
|
August 13, 2015
Pain in systemic inflammatory rheumatic diseases
Fabiola Atzeni, Ignazio Francesco Masala, Fausto Salaffi, et al.
Best Practice & Research. Clinical Rheumatology
|
June 9, 2019
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents
Fabiola Atzeni, Rossella Talotta, Ignazio Francesco Masala, et al.
Expert Review of Clinical Immunology
|
December 6, 2017
Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review
Fabiola Atzeni, Maria Chiara Gerardi, Giuseppe Barilaro, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Expert Opinion on Biological Therapy
|
June 20, 2022
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?
Fabiola Atzeni, Cesare Siragusano, Ignazio Francesco Masala, et al.
Clinical and Experimental Rheumatology
|
March 3, 2020
Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system
Fabiola Atzeni, Ignazio Francesco Masala, Mariateresa Cirillo, et al.
Expert Review of Clinical Immunology
|
September 20, 2024
Interstitial lung disease in rheumatic diseases: an update of the 2018 review
Fabiola Atzeni, Alessandra Alciati, Francesco Gozza, et al.
Expert Opinion on Biological Therapy
|
September 28, 2022
Effect of biological DMARDs and JAK inhibitors in pain of chronic inflammatory arthritis
Alessandra Alciati, Marco Di Carlo, Cesare Siragusano, et al.
Expert Review of Clinical Pharmacology
|
September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?
Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Autoimmunity Reviews
|
November 8, 2017
Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?
Piercarlo Sarzi-Puttini, Fabiola Atzeni, Ignazio Francesco Masala, et al.
Expert Opinion on Emerging Drugs
|
December 19, 2017
An update on emerging drugs for fibromyalgia treatment
Fabiola Atzeni, Maria Chiara Gerardi, Ignazio Francesco Masala, et al.
Best Practice & Research. Clinical Rheumatology
|
August 13, 2015
Pain in systemic inflammatory rheumatic diseases
Fabiola Atzeni, Ignazio Francesco Masala, Fausto Salaffi, et al.
Best Practice & Research. Clinical Rheumatology
|
June 9, 2019
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents
Fabiola Atzeni, Rossella Talotta, Ignazio Francesco Masala, et al.
Expert Review of Clinical Immunology
|
December 6, 2017
Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review
Fabiola Atzeni, Maria Chiara Gerardi, Giuseppe Barilaro, et al.
Page
of 4